What has happened to hemp in 2020?
Hemp has been around for centuries with documented use as far back as 8000bc, however due to legislations brought in throughout the early 20th century, it was ruled as a controlled substance along with its psychoactive counterpart.
The Hemp Farming Act was introduced in 2018 and the Hemp industry began to grow.
2019 saw the hemp industry boom with the popularity of CBD, and the growth is forecasted to continue.
There have been many changes and advancements around the Hemp industry over the last few years and 2020 is no exception.
So what has happened this year?
One of the biggest changes to the industry in 2020 is regulation. Many countries have brought in ways to try and regulate the industry and make it safer for consumers.
In 2019 it was announced Cannabidiol was being added to the list of novel foods in the EU. This means any edible product not commonly consumed before 2007 is classed as novel and needs to be regulated to ensure consumer safety. Many countries implemented the regulation immediately whilst others like the UK, gave time for Companies to prepare the paperwork required for a submission.
In the UK, From 1st April 2021 if companies don’t have a dossier submitted, they can be forced to remove products from sale.
2020 has seen many companies preparing dossiers to ensure the legal sale of products within the European market.
With Novel Foods Regulations being enforced from April, it’s predicted we will see an increase in Cosmetics, Skin care and Beauty products as these won’t be regulated by Novel Foods Regulations, but instead the Cosmetics EU Regulations which in comparison are a walk in the park.
However the European Commission has halted all applications for Novel foods whilst they decide whether they wish to class CBD as a Narcotic. The decision is due to be made in December.
2020 is seeing the rise of other cannabinoids and they seem to be hitting the market in a similar way to CBD. CBN and CBG are 2 of the next cannabinoids that seem to be hitting the market in a range of products.
Cannabigerol (CBG) and Cannabinol (CBN) are cannabinoids similar to CBD, but each have slightly different properties.
CBG is showing signs of antibacterial properties, whilst CBN is showing more sedative properties.
Due to its versatility, Hemp is being used for a number of applications across a range of industries.
Building materials (as we have discussed in our previous blog) such as Hemp based concrete products, and insulative materials are being designed and developed to create more eco friendly alternatives to what is already on the market.
More day to day textile such as sweatshirts, shopping bags and even full tailored suits are being produced by a range of companies.
More and more research is being done throughout the industry to help our understanding of the plant, what it can do and the cannabinoids it contains.
This year over $3 Million worth of research into CBD for the treatment of chronic pain has been funded by the US National Center for Complementary and Integrative Health (NCCIH).
The timing of this couldn’t be better with the National Institute for Health and Care Excellence (NICE) guidelines being brought in surrounding the prescription of Opioids, Corticosteroids, Non Steroidal Anti Inflammatories, and various other medications for the relief and treatment of chronic pain.
Even the US Drug Enforcement Agency (DEA) has increased the quota of Cannabis allowed to be used for research and studying by over 30%.
We can hope to broaden our understanding over the coming years.